4

MAIN DOCUMENT DESCRIPTION

Company: Protalix BioTherapeutics, Inc.
Filed: May 3, 2010
Period of Report: April 29, 2010
Accession Number: 0001209191-10-024792

View Document ↗ View on SEC.gov ↗